This review aimed to summarise the relative risk (RR) of the main symptoms of long COVID
in people infected with SARS-CoV-2 compared to uninfected controls, as well as the …

Background Long COVID occurs in those infected with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) whose symptoms persist or develop beyond the acute phase …

The development of technologies to protect or enhance memory in older people is an
enduring goal of translational medicine. Here we describe repetitive (4-day) transcranial …

Objectives To describe symptoms and symptom clusters of post-covid syndrome six to 12
months after acute infection, describe risk factors, and examine the association of symptom …

Importance Prolonged neuropsychiatric and cognitive symptoms are increasingly reported in
patients after COVID-19, but studies with well-matched controls are lacking. Objective To …

Cognitive post‐acute sequelae of SARS‐CoV‐2 (PASC) can occur after mild COVID‐19.
Detailed clinical characterizations may inform pathogenesis. We evaluated 22 adults …

Objective Long-term cognitive sequelae of COVID-19 have not been extensively studied.
This study provides initial results on cognitive outcomes in Post-Acute Sequelae of COVID …

Increasing data indicate that people infected with COVID-19 are at high risk for developing
long-term neurological complications, such as “brain fog” or cognitive impairment. However …

Severe acute respiratory disease coronavirus 2 (SARS-CoV-2) is responsible for the
coronavirus disease 2019 (COVID-19) pandemic. Although a primarily respiratory disease …

Many people with coronavirus disease 2019 (COVID-19) report varying degrees of memory
impairment. Neuroimaging techniques such as MRI and PET have been utilized to shed light …